Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Portfolio Pulse from Lisa Levin
The article lists the stocks that gained and lost the most in Friday's mid-day session. Among the gainers, PainReform Ltd. (PRFX) shares climbed 103% after announcing pricing of a $2.7 million concurrent registered direct offering and private placement. Frequency Therapeutics, Inc. (FREQ) gained 41.7% after agreeing to merge with Korro Bio. Among the losers, Theseus Pharmaceuticals, Inc. (THRX) shares dipped 69.9% after discontinuing enrollment in Phase 1/2 study and terminating development of THE-630 for gastrointestinal stromal tumors. State Street Corporation (STT) fell 10.5% after reporting slightly worse-than-expected second-quarter revenues and an increase in total expenses.
July 14, 2023 | 4:54 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
State Street Corporation fell 10.5% after reporting slightly worse-than-expected second-quarter revenues and an increase in total expenses.
The company's slightly worse-than-expected second-quarter revenues and an increase in total expenses have led to a decrease in its stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Theseus Pharmaceuticals, Inc. shares dipped 69.9% after discontinuing enrollment in Phase 1/2 study and terminating development of THE-630 for gastrointestinal stromal tumors.
The company's decision to discontinue enrollment in a Phase 1/2 study and terminate development of a drug has led to a significant decrease in its stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Frequency Therapeutics, Inc. gained 41.7% after agreeing to merge with Korro Bio.
The company's agreement to merge with Korro Bio has led to a significant increase in its stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
PainReform Ltd. shares climbed 103% after announcing pricing of a $2.7 million concurrent registered direct offering and private placement.
The announcement of a $2.7 million concurrent registered direct offering and private placement has led to a significant increase in the company's stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100